Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing Xenon's Phase 2 results for Azetukalner in patients with focal onset seizures (FOS) presented at the American Epilepsy Society Annual Meeting 2024.

Ticker(s): XENE

Who's the expert?

Institution: Atrium Health

General Neurologist
Manages around 500 patients with epilepsy

Interview Goal

This call will focus on the treatment landscape and potential use of Azetukalner for patients with focal onset seizures.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.